Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A | News
SANTA BARBARA, Calif., Feb. 2, 2021 /PRNewswire/ -- Bexson Biomedical, Inc., a research-stage company developing a subcutaneous ketamine treatment platform for...
SANTA BARBARA, Calif., Feb. 2, 2021 /PRNewswire/ -- Bexson Biomedical, Inc., a research-stage company developing a subcutaneous ketamine treatment platform for...
Over the last decade, federal officials misappropriated millions of dollars designated for biomedical research, including vaccine research, emergency preparedness for...
A map of NigeriaBy Joseph Erunke THE National Universities Commission, NUC, has engaged Nigerian foreign-based researchers on biomedical research as...